The FDA has approved revisions to the safety labeling for sitagliptin plus metformin HCl tablets (Janumet), colesevelam HCl tablets (WelChol), and rituximab intravenous injection (Rituxan). Medscape Medical News
Two new trials confirm that erectile dysfunction should be treated as a powerful early warning sign for myocardial infarction and other serious cardiovascular events in patients with diabetes. Medscape Medical News
The trial, comparing the crush technique with provisional T-stenting in bifurcation lesions, suggests that outcomes are similar, regardless of the technique used, at least in "true" bifurcation lesions where both the main vessel and side branch have significant stenosis. Heartwire
AHA 2007: A leading authority discusses whether the ability of the newer generation of beta-blockers to increase NO confers additional benefits for treatment of hypertension and heart failure. Medscape Cardiology
